ROSEKAMAL MCKINNEY: Open Payments
NPI 1457794885 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,217 in 98 payments from 15 companies in 2025. Trend: 2023 $505 · 2024 $1,103 · 2025 $2,217
Food & beverage: $2,217
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $316 |
| Indivior Inc. | 9 | $306 |
| Lundbeck LLC | 15 | $275 |
| Alkermes, Inc. | 10 | $206 |
| Janssen Pharmaceuticals, Inc | 8 | $180 |
| Otsuka America Pharmaceutical, Inc. | 8 | $148 |
| Neurocrine BioSciences, Inc. | 5 | $121 |
| Teva Pharmaceuticals USA, Inc. | 7 | $119 |
| E.R. Squibb & Sons, L.L.C. | 5 | $112 |
| Axsome Therapeutics, Inc. | 6 | $105 |
Products named: REXULTI, FANAPT, SUBLOCADE, ARISTADA, INGREZZA, COBENFY, Auvelity, BRIXADI.
Industry payments across AZ — which companies pay providers there.
